Literature DB >> 35874322

Dexmedetomidine as a rescue agent during intracranial neurosurgery in the setting of opioid tolerance.

S Mackie1, D Chambers2, J Sebastian2.   

Abstract

Dexmedetomidine is a versatile sedative agent widely used both in anaesthesia and intensive care. We present the case of a 32-year-old woman with a long-term history of non-prescribed intravenous opioid use who underwent elective resection of a skull base tumour. There was difficulty in achieving an adequate depth of anaesthesia despite the high levels of intravenous and volatile anaesthetic agent. Intra-operatively, a bolus and subsequent infusion of dexmedetomidine helped achieve an adequate depth of anaesthesia. This report highlights some of the benefits of dexmedetomidine for patients who are opioid tolerant, both intra- and postoperatively. It also demonstrates the wide range of beneficial effects dexmedetomidine could have when used as a rescue adjunct in neuroanaesthesia.
© 2022 Association of Anaesthetists.

Entities:  

Keywords:  dexmedetomidine; factors affecting anaesthetic depth; opioid tolerance

Year:  2022        PMID: 35874322      PMCID: PMC9296358          DOI: 10.1002/anr3.12178

Source DB:  PubMed          Journal:  Anaesth Rep        ISSN: 2637-3726


  8 in total

1.  Dexmedetomidine infusion for the management of opioid-induced hyperalgesia.

Authors:  Miles Belgrade; Sara Hall
Journal:  Pain Med       Date:  2010-10-28       Impact factor: 3.750

Review 2.  Perioperative management in the patient with substance abuse.

Authors:  Sharon Moran; Jason Isa; Susan Steinemann
Journal:  Surg Clin North Am       Date:  2015-01-09       Impact factor: 2.741

Review 3.  Remifentanil tolerance and hyperalgesia: short-term gain, long-term pain?

Authors:  E H Y Yu; D H D Tran; S W Lam; M G Irwin
Journal:  Anaesthesia       Date:  2016-11       Impact factor: 6.955

4.  [Postpartum hemorrhage and pregnancy induced hypertension during emergency lower segment cesarean section: dexmedetomidine to our rescue].

Authors:  Uma Hariharan
Journal:  Rev Bras Anestesiol       Date:  2017-05-20       Impact factor: 0.964

5.  Dexmedetomidine as an anesthetic adjuvant for intracranial procedures: meta-analysis of randomized controlled trials.

Authors:  Ke Peng; Shaoru Wu; Huayue Liu; Fuhai Ji
Journal:  J Clin Neurosci       Date:  2014-06-25       Impact factor: 1.961

Review 6.  Perioperative dexmedetomidine administration to prevent delirium in adults after non-cardiac surgery: A systematic review and meta-analysis.

Authors:  Chaosheng Qin; Yihong Jiang; Cheng Lin; Aiguo Li; Jingchen Liu
Journal:  J Clin Anesth       Date:  2021-04-28       Impact factor: 9.452

7.  Dexmedetomidine: present and future directions.

Authors:  Seongheon Lee
Journal:  Korean J Anesthesiol       Date:  2019-06-21

8.  Dexmedetomidine alleviates neuroinflammation, restores sleep disorders and neurobehavioral abnormalities in rats with minimal hepatic encephalopathy.

Authors:  Yu Zhang; Su-Lan Tan; Juan Du; Ye Chen; Jing Jia; Jian-Guo Feng; Ke-Xuan Liu; Jun Zhou
Journal:  Int Immunopharmacol       Date:  2021-05-24       Impact factor: 4.932

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.